We are live on ! Find out more
LMAT icon

LeMaitre Vascular

143 hedge funds and large institutions have $419M invested in LeMaitre Vascular in 2020 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 60 increasing their positions, 46 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 46

2.77% less ownership

Funds ownership: 86.72%83.95% (-2.8%)

13% less funds holding

Funds holding: 165143 (-22)

33% less capital invested

Capital invested by funds: $623M → $419M (-$204M)

56% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 34

Holders
143
Holders Change
-22
Holders Change %
-13.33%
% of All Funds
3.14%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
60
Reduced
46
Closed
34
Calls
Puts
Net Calls
Net Calls Change

LMAT Hedge Fund Activity: Q1 2020 in Review

143 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q1 2020, worth a combined $419M — down 33% from $623M a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of LMAT and 15 opened new positions — a net loss of 19 holders — while 46 trimmed existing stakes and 60 added.

The largest buyer was Grandeur Peak Global Advisors, opening a new position worth an estimated $3.78M. The largest seller was Janus Henderson Group, cutting an estimated $20.1M.

  • 143 institutional investors held LeMaitre Vascular (LMAT) as of Q1 2020, down from 165 in Q4 2019.
  • Funds reported $419M of LeMaitre Vascular stock for Q1 2020, down 33% quarter-over-quarter.
  • 15 funds opened new LeMaitre Vascular positions in Q1 2020 and 34 closed out, a net change of -19 holders.
  • The largest LeMaitre Vascular buyer in Q1 2020 was Grandeur Peak Global Advisors, an estimated $3.78M added.
  • The largest LeMaitre Vascular seller in Q1 2020 was Janus Henderson Group, an estimated $20.1M sold.

Based on aggregated 13F filings for Q1 2020.